Enhanced quality small molecules as ancillary materials
Standard research reagents are suitable for the early stages of cell therapy development, but to ensure later downstream success investing in high-quality ancillary products at the research phase is important.
View this infographic to discover the benefits of Ancillary Material Grade small molecules and how switching early can reduce the risk, time, and cost associated with revalidating assays and protocols.
This infographic is part of the RegMedNet In Focus on small molecules. Discover expert opinions on this topic by visiting our feature homepage.
RMN In Focus Bio-Techne small molecules Small Size
Illustrated by Tobias Dumbraveanu (Future Science Group, London, UK).